InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
03/31/24 1:48 PM
profile icon
clydesur Free
02/09/24 9:36 AM
profile icon
Monksdream PremiumMember
01/28/24 3:09 PM
profile icon
Monksdream PremiumMember
01/08/24 3:37 PM
profile icon
Femto99 Free
02/11/21 12:16 PM
profile icon
Femto99 Free
02/11/21 11:02 AM
profile icon
Stock_Barber PremiumMember
02/09/21 4:01 PM
profile icon
ClayTrader Free
02/09/21 3:58 PM
profile icon
Stock_Barber PremiumMember
02/09/21 9:24 AM
profile icon
make it happen Free
02/09/21 9:19 AM
profile icon
make it happen Free
02/09/21 9:18 AM
profile icon
make it happen Free
02/09/21 8:04 AM
profile icon
TFMG Free
06/23/20 10:23 PM
profile icon
whytestocks Free
04/22/19 2:50 PM
profile icon
whytestocks Free
04/03/19 1:24 PM
profile icon
stocktrademan Free
04/02/19 12:58 PM
profile icon
whytestocks Free
03/14/19 8:20 AM
profile icon
Lone Wolf Free
10/10/17 8:52 AM
profile icon
TheFinalCD PremiumMember
10/10/17 8:48 AM
profile icon
Warchest Free
01/09/17 3:20 PM
profile icon
ming1234 Free
01/09/17 3:10 PM
profile icon
Warchest Free
01/09/17 1:35 PM
profile icon
Warchest Free
01/09/17 1:30 PM
profile icon
Toxic Avenger Free
12/12/16 11:01 AM
profile icon
MSparks6 Free
11/22/16 10:06 AM
profile icon
Toxic Avenger Free
11/22/16 8:12 AM
profile icon
Iam_in Free
11/22/16 8:08 AM
profile icon
Iam_in Free
11/22/16 8:06 AM
profile icon
Iam_in Free
11/22/16 8:03 AM
profile icon
Iam_in Free
11/22/16 8:01 AM
profile icon
Toxic Avenger Free
11/21/16 7:11 PM
profile icon
ClayTrader Free
11/21/16 4:26 PM
profile icon
beginneer Free
11/21/16 9:49 AM
profile icon
beginneer Free
11/21/16 9:45 AM
profile icon
Toxic Avenger Free
11/21/16 9:24 AM
profile icon
ClayTrader Free
11/18/16 4:46 PM
profile icon
beginneer Free
11/18/16 3:43 PM
profile icon
Toxic Avenger Free
11/18/16 2:59 PM
profile icon
beginneer Free
11/18/16 2:46 PM
profile icon
Toxic Avenger Free
11/14/16 1:04 PM
profile icon
Toxic Avenger Free
11/08/16 8:47 PM
profile icon
MSparks6 Free
11/03/16 7:49 PM

KalVista Pharmaceuticals (KALV) RSS Feed

Followers
13
Posters
84
Posts (Today)
0
Posts (Total)
431
Created
04/24/15
Type
Free
Moderators

KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need.

Medic-patient meeting

KalVista is developing plasma kallikrein inhibitors for the treatment of hereditary angioedema (HAE) and diabetic macular edema (DME); indications where excessive plasma kallikrein activity is implicated, but where there remains substantial unmet clinical need. KalVista has built an expanding clinical and advanced preclinical product pipeline targeting multiple routes of administration to treat these diseases.

Research and Development

KalVista’s initial focus is on advancing a portfolio of orally delivered plasma kallikrein inhibitors for the treatment of HAE. The most advanced program, KVD818, is in Phase I clinical studies and additional molecules are expected to reach the clinic in 2017. KalVista’s most advanced program, an intravitreally administered plasma kallikrein inhibitor, has successfully completed its first-in-human study in patients with DME and is being prepared for Phase 2 clinical studies.

KalVista has an R&D team with an established track record in the pharmaceutical development of small molecule protease inhibitors, world-leading expertise in the role of plasma kallikrein in disease, and a management team with proven experience in bringing small molecules through the clinic to commercialization.

KalVista has offices in Cambridge, MA, USA and Salisbury, UK.




Kal Vista Merger with Carbylan Announcement
New Post